A review of the New Zealand National Stroke Register has revealed an increased rate of reperfusion therapy between 2015 and 2020, driven by an increase in the use of stroke clot retrieval (from 0.5 to 5.5% of patients). The rate of intravenous thrombolysis was 6.5% in 2015 and 11.3% in 2020. In 2019, females were less likely to receive intravenous thrombolysis than males. Ethnicity had no impact on overall reperfusion rates. However, median door-to-needle time over the period 2018-2020 was significantly longer for Māori patients compared with NZ Europeans.